Balance Sheet - ArriVent BioPharma, Inc. (AVBP)
$(Billion, Million)| Sep-25 | Sep-24 | Sep-23 | Sep-22 | Sep-21 | |
|---|---|---|---|---|---|
| Total cash and short-term investments | 312.82 | 218.86 | 150.39 | 163.37 | 37.28 |
| Accounts receivable, net | 0.50 | 0.76 | 0.50 | 0.25 | |
| Inventories | -0.24 | ||||
| Other current assets | 20.08 | 7.62 | 9.58 | 19.25 | 5.67 |
| Total current assets | 332.90 | 226.98 | 159.97 | 182.62 | 42.95 |
| Total non-current assets | 0.27 | 47.96 | 3.13 | 0.21 | 0.09 |
| Total assets | 333.17 | 274.94 | 163.10 | 182.83 | 43.04 |
| Total current liabilities | 25.95 | 17.27 | 11.62 | 8.36 | 1.82 |
| Total non-current liabilities | 0.00 | 0.01 | 0.18 | 0.01 | 0.00 |
| Total liabilities | 25.95 | 17.29 | 11.80 | 8.37 | 1.82 |
| Total stockholders' equity | 307.22 | 257.65 | 151.30 | 174.46 | 41.22 |
| Common shares outstanding | 38 | 31 | 32 | 33 | 1 |
Show Quarterly Balance Sheet
Balance Sheet - ArriVent BioPharma, Inc. (AVBP)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 326.38 | 312.82 | 300.27 | 235.69 | 176.08 | 218.86 | 282.86 | 298.67 | 317.39 | 150.39 | 166.36 | 182.83 | 163.37 | 163.37 | 0.00 | 0.00 | 37.28 |
| Accounts receivable, net | 0.51 | 0.51 | 0.51 | 0.50 | 0.50 | 0.75 | 0.88 | 0.76 | 1.09 | 0.26 | 0.50 | ||||||
| Other current assets | 22.32 | 20.08 | 20.45 | 13.96 | 9.20 | 7.62 | 9.04 | 9.09 | 9.21 | 9.58 | 13.62 | 15.85 | 19.25 | -37.28 | |||
| Total current assets | 348.70 | 332.90 | 321.22 | 250.15 | 185.79 | 226.98 | 292.40 | 308.51 | 327.48 | 159.97 | 179.98 | 198.69 | 163.37 | 182.62 | 37.28 | ||
| Total non-current assets | 0.60 | 0.27 | 5.34 | 19.36 | 29.71 | 47.96 | 0.31 | 0.34 | 0.36 | 3.13 | 2.01 | 0.16 | -163.37 | 0.21 | -37.28 | ||
| Total assets | 349.30 | 333.17 | 326.56 | 269.51 | 215.50 | 274.94 | 292.71 | 308.86 | 327.84 | 163.10 | 181.99 | 198.84 | 182.83 | ||||
| Total current liabilities | 25.00 | 25.95 | 21.56 | 19.64 | 12.95 | 17.27 | 15.16 | 12.10 | 9.98 | 11.62 | 10.10 | 12.81 | 8.36 | ||||
| Total non-current liabilities | 0.32 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 | 0.10 | 0.14 | 0.18 | 304.49 | 0.00 | 0.01 | -41.22 | |||
| Total liabilities | 25.32 | 25.95 | 21.56 | 19.64 | 12.95 | 17.29 | 15.22 | 12.20 | 10.12 | 11.80 | 10.10 | 12.81 | 8.37 | -41.22 | |||
| Total stockholders' equity | 323.98 | 307.22 | 305.00 | 249.87 | 202.54 | 257.65 | 277.49 | 296.66 | 317.72 | 151.30 | 171.89 | 186.03 | 174.46 | 174.46 | 41.22 | ||
| Common shares outstanding | 45 | 38 | 42 | 35 | 34 | 34 | 34 | 34 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 1 | 1 |